Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

CYP2C9 polymorphisms and CYP2C9*2 genotyping primers

Joyce A Goldstein

    British Journal of Clinical Pharmacology
    |April 23, 2002
    PubMed
    Summary

    No abstract available in PubMed .

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    CYP2C8 Is a Novel Target of Peroxisome Proliferator-Activated Receptor α in Human Liver.

    Molecular pharmacology·2015
    Same author

    Epigenetic modification of histone 3 lysine 27: mediator subunit MED25 is required for the dissociation of polycomb repressive complex 2 from the promoter of cytochrome P450 2C9.

    The Journal of biological chemistry·2014
    Same author

    Med25 is required for estrogen receptor alpha (ERα)-mediated regulation of human CYP2C9 expression.

    Biochemical pharmacology·2014
    Same author

    The influence of the CYP2C19*10 allele on clopidogrel activation and CYP2C19*2 genotyping.

    Pharmacogenetics and genomics·2014
    Same author

    Regulation of human CYP2C9 expression by electrophilic stress involves activator protein 1 activation and DNA looping.

    Molecular pharmacology·2014
    Same author

    RBCK1, an E3 ubiquitin ligase, interacts with and ubiquinates the human pregnane X receptor.

    Drug metabolism and disposition: the biological fate of chemicals·2012